AYTU BIOPHARMA, INC. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated May 18, 2022, discloses the results of the 2022 Annual Meeting of Stockholders for Aytu BioPharma, Inc. The meeting was held on May 18, 2022, with 20,034,954 shares present or represented out of 33,355,935 shares outstanding on the record date.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Voting Results
The filing details the outcomes of four specific matters voted on by security holders:
- Election of Directors: Stockholders elected five members to the Board of Directors: Joshua R. Disbrow, Gary V. Cantrell, Carl C. Dockery, John A. Donofrio, Jr., and Michael E. Macaluso. All candidates received a majority of votes cast, though significant numbers of votes were withheld and broker non-votes occurred.
- Appointment of Auditors: The ratification of Plante & Moran, PLLC as the independent registered public accounting firm for the fiscal year ending June 30, 2022, was approved (16,596,117 votes in favor).
- Executive Compensation (Say-on-Pay): The advisory vote on executive compensation was approved (7,386,646 votes in favor).
- Frequency of Say-on-Pay Votes: Stockholders voted on the frequency of future advisory votes. While 5,841,439 votes favored an annual frequency, 5,309,518 votes favored a three-year frequency. Despite the split vote, the Board determined to hold future Say-on-Pay votes on an annual basis until the next required frequency vote in 2028.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding business outlook, guidance, risks, contingencies, or unusual items. It is strictly a report of the annual meeting vote tallies.
Key Facts for Investor Verification
- Verify the final composition of the Board of Directors following the election of the five new members.
- Note the Board's decision to hold annual Say-on-Pay votes despite a significant portion of the vote favoring a three-year frequency.
- Confirm the appointment of Plante & Moran, PLLC as the auditor for the fiscal year ending June 30, 2022.
- Review the high number of broker non-votes (8,531,563) recorded for the director elections and executive compensation vote.